X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
index medicus (21) 21
receptor-mediated endocytosis (18) 18
animals (17) 17
oncology (16) 16
pharmacology & pharmacy (15) 15
radiology, nuclear medicine & medical imaging (12) 12
receptor-mediated radiotherapy (12) 12
male (11) 11
female (10) 10
tumors (10) 10
apoptosis (9) 9
cancer (9) 9
in-vivo (9) 9
mice (9) 9
review (9) 9
drug delivery systems (8) 8
middle aged (8) 8
nanoparticles (8) 8
aged (7) 7
blood-brain barrier (7) 7
cell line, tumor (7) 7
health aspects (7) 7
octreotide - analogs & derivatives (7) 7
radionuclide therapy (7) 7
radiotherapy (7) 7
therapy (7) 7
adult (6) 6
glioma (6) 6
nanotechnology (6) 6
neoplasms - radiotherapy (6) 6
radionuclide imaging (6) 6
radiopharmaceuticals - therapeutic use (6) 6
receptor-mediated apoptosis (6) 6
research (6) 6
signal transduction (6) 6
cancer cells (5) 5
cancer therapies (5) 5
cellular signal transduction (5) 5
central-nervous-system (5) 5
chemistry, multidisciplinary (5) 5
chemotherapy (5) 5
drug delivery (5) 5
gene therapy (5) 5
in-vitro (5) 5
octreotide - therapeutic use (5) 5
peptides (5) 5
somatostatin (5) 5
somatostatin receptor-mediated internal radiotherapy (5) 5
y-90-dotatoc (5) 5
yttrium-90 (5) 5
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - pharmacology (4) 4
antineoplastic agents - therapeutic use (4) 4
biochemistry & molecular biology (4) 4
blood–brain barrier (4) 4
care and treatment (4) 4
cell biology (4) 4
drug delivery systems - methods (4) 4
endocytosis (4) 4
medicine & public health (4) 4
neoplasms - metabolism (4) 4
neuroendocrine tumors (4) 4
nf-kappa-b (4) 4
octreotide (4) 4
phase-i (4) 4
proteins (4) 4
tissue distribution (4) 4
transferrin (4) 4
yttrium radioisotopes - therapeutic use (4) 4
apoptosis - drug effects (3) 3
blood-brain barrier - drug effects (3) 3
blood-brain barrier - metabolism (3) 3
brain cancer (3) 3
brain neoplasms - drug therapy (3) 3
cell-penetrating peptides (3) 3
cells (3) 3
chemistry (3) 3
chemistry, medicinal (3) 3
chronic lymphocytic-leukemia (3) 3
cytotoxicity (3) 3
delivery (3) 3
diagnosis (3) 3
dotatoc (3) 3
drug carriers (3) 3
drug-delivery (3) 3
drugs (3) 3
endocrinology & metabolism (3) 3
endothelial-cells (3) 3
expression (3) 3
gene delivery (3) 3
gene transfer techniques (3) 3
imaging / radiology (3) 3
indium-111 (3) 3
kidney - diagnostic imaging (3) 3
kidney - metabolism (3) 3
life sciences (3) 3
liposomes (3) 3
low-density-lipoprotein (3) 3
medicine, research & experimental (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 2001, Volume 74, Issue 1, pp. 115 - 128
Journal Article
LUNG CANCER, ISSN 0169-5002, 09/2004, Volume 45, Issue 3, pp. 365 - 371
Background: Some small cell lung carcinomas (SCLC) express neuroendocrine markers, such as somatostatin receptors. Therefore, somatostatin analogues can be... 
Y-90-DOTATOC | somatostatin receptor | Y-90 | NEUROENDOCRINE TUMORS | DOTATOC | MEDULLARY-THYROID CANCER | RECEPTOR-MEDIATED RADIOTHERAPY | PHASE-II | octreoscan scintigraphy | ONCOLOGY | RESPIRATORY SYSTEM | RADIONUCLIDE THERAPY | OCTREOTIDE SCINTIGRAPHY
Journal Article
Journal Article
Neuroendocrinology, ISSN 0028-3835, 2004, Volume 80, Issue 6, pp. 394 - 424
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, ISSN 0340-6997, 04/2001, Volume 28, Issue 4, pp. 426 - 434
A newly developed somatostatin radioligand, DOTA-[D-Phe(1)-Tyr(3)]-octreotide (DOTATOC), has been synthesised for therapeutic purposes, because of its stable... 
OCTREOTIDE | Y-90/In-111-DOTATOC | Y-90 DOTATOC | IN-111-DOTA-TYR-OCTREOTIDE | SUBTYPES | SCINTIGRAPHY | peptides | somatostatin analogue | SOMATOSTATIN RECEPTORS | BIODISTRIBUTION | CANCER | TUMORS | RADIONUCLIDE THERAPY | receptor-mediated radiotherapy | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 6/2012, Volume 29, Issue 6, pp. 1495 - 1505
Nanomedicines represent an alternative for the treatment of aggressive glioblastoma tumors. Behaviour of PLGA-nanoparticles (NPs) was here investigated as a... 
Biomedical Engineering | Biochemistry, general | targeting | Biomedicine | blood–brain barrier | Pharmacy | stealth | Medical Law | glioma | Pharmacology/Toxicology | PLGA nanocarriers | central nervous system | blood-brain barrier | TARGETED DRUG-DELIVERY | GENE DELIVERY | DOXORUBICIN | LIPID NANOCAPSULES | CHEMISTRY, MULTIDISCIPLINARY | TEMOZOLOMIDE | RECEPTOR-MEDIATED ENDOCYTOSIS | ANTICANCER | TRANSCYTOSIS | PHARMACOLOGY & PHARMACY | RADIOTHERAPY | TECHNOLOGY | Capillary Permeability | Injections, Intravenous | Lactic Acid - blood | Rats, Inbred F344 | Brain Neoplasms - pathology | Half-Life | Transferrin - administration & dosage | Monocytes - metabolism | Brain Neoplasms - metabolism | Drug Carriers | Glioma - metabolism | Nanoparticles | Tissue Distribution | Lactic Acid - pharmacokinetics | Endocytosis | Glioma - pathology | Drug Compounding | Female | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | Lactic Acid - chemistry | Caveolae - metabolism | Rats | Technology, Pharmaceutical - methods | Receptors, Transferrin - metabolism | Chemistry, Pharmaceutical | Clathrin - metabolism | Blood-Brain Barrier - metabolism | Macrophages - metabolism | Animals | Adsorption | Polyglycolic Acid - pharmacokinetics | Polyglycolic Acid - chemistry | Transferrin - chemistry | Cell Line, Tumor | Transferrin - pharmacokinetics | Mice | Nanotechnology | Astrocytes - metabolism | Transferrin | Gliomas | Brain cancer | Brain tumors | Nurses | Cancer cells | Albumin | Macrophages | Tumors | Cancer | Nervous system | Pharmacology | Bovine serum albumin | Astrocytes | Glioblastoma | Data processing | Coatings | Monocytes | Antitumor agents | nanoparticles | Blood circulation | Zeta potential | Glioma cells | polylactide-co-glycolide
Journal Article
Journal Article